# Cognitive Function After Treatment of Primary CNS Malignancy

> **NCT03055364** · — · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 129 (actual)

## Conditions studied

- CNS Malignancy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03055364
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-13
- **Primary completion:** 2023-11-02
- **Final completion:** 2023-11-02
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2024-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03055364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03055364, "Cognitive Function After Treatment of Primary CNS Malignancy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03055364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*